This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Hi-Tech Pharmacal Reports Sales Of $58.6 Million For The Second Quarter Ended October 31, 2013

Stocks in this article: HITK

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the second fiscal quarter ended October 31, 2013.

  • Net sales of $58.6 million for the second quarter compared to $57.5 million for the same prior year period
  • GAAP income of $1.2 million or $0.08 per diluted share for the second quarter
  • Adjusted non-GAAP net income of $10.0 million or $0.71 per diluted share for the second quarter
  • Net sales of $109.1 million for the six month period compared to $109.6 million for the same prior year period
  • GAAP income of $5.7 million or $0.41 per diluted share for the six month period
  • Adjusted non-GAAP net income of $17.7 million or $1.26 per diluted share for the six month period
Three Months Ended October 31, Six Months Ended October 31,
2013     2012 2013     2012
Net sales $ 58,601,000 $ 57,537,000 $ 109,102,000 $ 109,580,000
GAAP net income $ 1,187,000 $ 8,924,000 $ 5,737,000 $ 14,928,000
Adjusted non-GAAP net income $ 10,013,000 $ 11,426,000 $ 17,727,000 $ 19,740,000
GAAP Diluted EPS $ 0.08 $ 0.66 $ 0.41 $ 1.10
Adjusted non-GAAP Diluted EPS $ 0.71 $ 0.84 $ 1.26 $ 1.45
Diluted Shares 14,066,000 13,584,000 14,055,000 13,573,000

 (see Table I for reconciliation to GAAP numbers)

Quarterly Results

For the three months ended October 31, 2013, the Company reported net sales of $58,601,000, an increase of 2% from $57,537,000 for the same period last year.

1 of 7

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,064.56 +10.85 0.06%
S&P 500 2,092.84 +4.07 0.19%
NASDAQ 4,811.9330 +5.0740 0.11%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs